Treleaven JG - Search Results

1

The combination of cyclophosphomide, thalidomide and dexamethasone is an effective alternative to cyclophosphamide - vincristine - doxorubicin - methylprednisolone as induction chemotherapy prior to autologous transplantation for multiple myeloma: a case-matched analysis.

Wu P, Davies FE, Horton C, Jenner MW, Krishnan B, Alvares CL, Saso R, McCormack R, Dines S, Treleaven JG, Potter MN, Ethell ME, Morgan GJ. Wu P, et al. Among authors: treleaven jg. Leuk Lymphoma. 2006 Nov;47(11):2335-8. doi: 10.1080/10428190600821955. Leuk Lymphoma. 2006. PMID: 17107906

2

Long-term outcomes of previously untreated myeloma patients: responses to induction chemotherapy and high-dose melphalan incorporated within a risk stratification model can help to direct the use of novel treatments.

Alvares CL, Davies FE, Horton C, Patel G, Powles R, Sirohi B, Zuha R, Gatt A, Saso R, Treleaven JG, Dearden CE, Potter MN, Ethell ME, Morgan GJ. Alvares CL, et al. Among authors: treleaven jg. Br J Haematol. 2005 Jun;129(5):607-14. doi: 10.1111/j.1365-2141.2005.05514.x. Br J Haematol. 2005. PMID: 15916682 Free article.

3

Outcome of high-dose cytarabine-based induction therapy followed by hematopoietic stem cell transplantation in acute myeloid leukemia: influence of karyotype.

Sirohi B, Powles R, Singhal S, Smith K, Jones RL, Saso R, Kulkarni S, Treleaven J, Swansbury GJ, Potter M, Morgan G, Mehta J. Sirohi B, et al. Leuk Lymphoma. 2008 Dec;49(12):2284-90. doi: 10.1080/10428190802474454. Leuk Lymphoma. 2008. PMID: 19052975 Clinical Trial.

4

Clinical profile and outcome of urotheliotropic viral haemorrhagic cystitis following haematopoietic stem cell transplantation: a 7-year tertiary centre analysis.

Anoop P, Shaw BE, Riley U, Ethell ME, Taj M, Lancaster DL, Atra A, Saso R, Littlewood S, Mohammed K, Davies F, Treleaven J, Morgan GJ, Potter MN. Anoop P, et al. Hematology. 2011 Jul;16(4):213-20. doi: 10.1179/102453311X13025568941763. Hematology. 2011. PMID: 21756537

5

Re-use of the original infusional induction chemotherapy as salvage therapy in myeloma patients relapsing after one autograft.

Sirohi B, Powles R, Rudin C, Singhal S, Kulkarni S, Saso R, Horton C, Mehta J, Treleaven J. Sirohi B, et al. Hematology. 2005 Oct;10(5):361-4. doi: 10.1080/10245330500234369. Hematology. 2005. PMID: 16203605

6

Collection of peripheral blood stem cells in new patients with myeloma receiving minimal or no prior cytoreductive therapy.

Sirohi B, Powles R, Cavanagh J, Oakervee H, Dyer P, Rintala T, Kulkarni S, Rudin C, Horton C, Treleaven J, Morgan G. Sirohi B, et al. Hematology. 2007 Apr;12(2):113-5. doi: 10.1080/10245330601111631. Hematology. 2007. PMID: 17454191

7

Long-term safety of GM-CSF (molgramostim) administration after allogeneic bone marrow transplantation for hematologic malignancies: five-year follow-up of a double-blind randomized placebo-controlled study.

Singhal S, Powles R, Treleaven J, Horton C, Mehta J. Singhal S, et al. Leuk Lymphoma. 1997 Jan;24(3-4):301-7. doi: 10.3109/10428199709039017. Leuk Lymphoma. 1997. PMID: 9156659 Clinical Trial.

8

Comparison of interferon tolerance after autologous bone marrow or peripheral blood stem cell transplants for myeloma patients who have responded to induction therapy.

Powles R, Raje N, Horton C, Mehta J, Singhal S, Hickish T, Viner C, Milan S, Treleaven J, Cunningham D. Powles R, et al. Leuk Lymphoma. 1996 May;21(5-6):421-7. doi: 10.3109/10428199609093439. Leuk Lymphoma. 1996. PMID: 9172806 Clinical Trial.

9

Cytomegaloviremia after autografting for leukemia: clinical significance and lack of effect on engraftment.

Singhal S, Powles R, Treleaven J, Horton C, Pinkerton CR, Meller S, Mehta J. Singhal S, et al. Leukemia. 1997 Jun;11(6):835-8. doi: 10.1038/sj.leu.2400672. Leukemia. 1997. PMID: 9177437

10

Autologous transplantation with CD52 monoclonal antibody-purged marrow for acute lymphoblastic leukemia: long-term follow-up.

Mehta J, Powles R, Treleaven J, Horton C, Shepherd V, Hale G, Waldmann H, Singhal S. Mehta J, et al. Leuk Lymphoma. 1997 May;25(5-6):479-86. doi: 10.3109/10428199709039035. Leuk Lymphoma. 1997. PMID: 9250818 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

200 results

Search Page

Filters